OrbiMed Capital GP III LLC, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), sold 42,100 shares at $10.86 ($465K) on 2012-02-29, disclosed to the SEC on 2012-02-29.
Open-market sale of $465k PCRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.05 | 300 | $3K | 0.7% |
| 2 | $11.05 | 28,700 | $317K | 68.2% |
| 3 | $11.12 | 100 | $1K | 0.2% |
| 4 | $11.12 | 10,000 | $111K | 23.9% |
| 5 | $10.86 | 3,000 | $33K | 7.0% |
| Total | $11.05 avg | 42,100 |
| $465K |
| 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |